Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Kalobios Pharmaceuticals Inc (KBIO)

Kalobios Pharmaceuticals Inc (KBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Kalobios Pharmaceuticals Inc 1000 Marina Blvd. Suite 250 Brisbane CA 94005 USA

www.kalobios.com P: 650-243-3100

Description:

KaloBios Pharmaceuticals, Inc. is a biopharmaceutical company. The Company develops monoclonal antibody therapeutics for the treatment of respiratory diseases and cancer. KaloBios Pharmaceuticals, Inc. is based in South San Francisco, California.

Key Statistics

Overview:

Market Capitalization, $K 32,806
Shares Outstanding, K 14,980
Annual Sales, $ 0 K
Annual Net Income, $ -27,010 K
60-Month Beta 2.99
% of Insider Shareholders 2.89%
% of Institutional Shareholders 0.00%

Growth:

1-Year Return -44.70%
3-Year Return 14.66%
5-Year Return 0.00%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 09/22/17
Earnings Per Share ttm -0.67
EPS Growth vs. Prev Year 43.08%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

KBIO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -302.86%
Profit Margin % 0.00%
Debt/Equity -0.29
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 0.00
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar